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In the prospective study conducted in Israel by Boltin 
et  al among primary care physicians (PCPs), the rate of 
recommendation of a 4-drug treatment protocol for Helicobacter 
pylori (H. pylori) eradication increased from 3.8% in 2015 to 
37.1% in 2018 (P<0.001) [1]. Likewise, the number of PCPs 
who recommended bismuth-  or levofloxacin-based therapy 
for second-line treatment increased from 30.3% in 2015 to 
77.1% in 2018 (P<0.001). Independent predictors for a 4-drug 
treatment protocol included central clinic location, exposure to 
printed educational materials, and exposure to the social media 
platform. In contrast, there were no independent predictors of 
compliance with second-line treatment. Accordingly, the authors 
concluded that PCP compliance with  H. pylori  guidelines 
remains suboptimal but educational initiatives and direct web-
based interaction between PCPs and gastroenterologists may be 
effective [1]. Focusing on the options chosen in the second-line 
treatment, we observed that the number of PCPs who repeated 
the first-line treatment decreased from 6.7% to 5.9%. Although 
this reduction was not statistically significant (P=0.58), it 
indicates a positive cultural trend.
In other regions of the world, opposite trends have 
recently been reported. Li et al found that in Shanghai, China, 
clarithromycin-containing regimens were used repeatedly 
to eradicate H. pylori infection in 60.8% of patients, while 
levofloxacin-containing regimens were repeated in 30.0% [2]. 
In Turin, northwestern Italy, we found that during the period 
2014-2016 the same treatment was repeated after a failure in 
15.1% of patients, compared with 3.9% in the period 2004-
2006 (P<0.0001). Furthermore, while in the period 2004-2006 
all repetitions were prescribed by PCPs, over the period 2014-
2016 PCPs were responsible for 78.8% of prescriptions. In the 
specialist setting, the repetition of the same regimen ranged 
from 0% in the period 2004-2006 to 18.2% during the period 
2014-2016, at the limit of statistical significance (P=0.088) [3]. 
Hence, in our area there is an increasing trend to repeat the 
same treatment after a first failure, despite a long background 
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in the management of H. pylori infection [4]. This could be due 
to the reduced interest and knowledge concerning H. pylori 
eradication, at both general and specialist levels. Nevertheless, 
it is possible that the lack of a health informatics network 
could limit the availability of patients’ data, inducing errors 
such as the repetition of the same treatment when patient 
documentation on previous treatment is not available.
In conclusion, the interesting work by Boltin et  al 
encourages  the planning of updating courses or online 
networks dedicated to PCPs as well as specialists for medical 
re-education, aiming to stimulate the appropriate application 
of International Guidelines concerning the various steps of 
H. pylori treatment [5].
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